Skip to main content
Clinical Trials/NCT05840627
NCT05840627CompletedNot Applicable

The Effect of Daily Consumption of a Fruit Juice on Acute Satiety Response and Gut Microbiota Changes in Healthy Adults

Universidade Nova de Lisboa1 site in 1 country12 target enrollmentStarted: February 28, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
12
Locations
1
Primary Endpoint
Changes in the iAUC (pmol/L*min) for ghrelin

Study Overview

Brief Summary

The "cLabel+ Innovative natural, nutritious and consumer-oriented clean label food" is a research and technological development project centered on responding to the challenges facing the food industry. It is focused on the concept of "clean label", which emerges as one of the major current trends in the sector, given the growing number of consumers who are increasingly aware and eager for information, who are looking for alternative, more transparent and natural food products.

Thus, one of the aims of the cLabel+ project is to research the macronutrients and phenolic compounds present in food matrices and achieve a clean label positioning for the final products developed. This single group assignment clinical trial aims to evaluate the effect of daily consumption of a fruit juice, developed as part of the collaborative project cLabel+, on gut microbiota composition and diversity in healthy adults. It is also intended to study the acute metabolic effect, namely in terms of appetite control, and lipid and glucose metabolism.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Men or women
  • •Adults (age ≥ 18 years)
  • •Filling informed consent

Exclusion Criteria

  • •Obesity (body mass index ≥ 30.0 kg/m2).
  • •Daily consumption of fruit juices in the month prior to the start of the study.
  • •Individuals with diagnosed food allergies or intolerances to the components being tested.
  • •Use of pro/prebiotics or fibre as a dietary supplement or any food/molecule that modifies intestinal transit time 6 weeks before recruitment.
  • •Use of laxatives 6 weeks before recruitment.
  • •Recent weight loss or weight gain of more than 10% in the last 3 months.
  • •Adherence to restrictive weight loss diets or specific dietary pattern (e.g., palaeolithic diet, Atkins, flexitarian, ketogenic, vegan).
  • •Diagnosis of gastrointestinal pathology, hormonal or thyroid pathology, autoimmune diseases, chronic use of corticosteroids, psychiatric disease, or diabetes mellitus.
  • •Having taken antibiotics within the 12 weeks prior to beginning the study.
  • •Excessive consumption of alcoholic beverages (>14 and >8 units/week for men and women, respectively).
  • •Pregnant or breastfeeding.
  • •Participation in another clinical trial within the past 3 months that the Principal Investigator believes may compromise the results of the trial (e.g., clinical trial with an effect on the composition and diversity of the gut microbiota).

Arms & Interventions

Fruit juice

Experimental

Intervention: Fruit juice (Other)

Outcomes

Primary Outcomes

Changes in the iAUC (pmol/L*min) for ghrelin

Time Frame: 14 days

Ghrelin will be measured in fasting and every 30 minutes up to 3 hours. The iAUC (pmol/L\*min) for ghrelin will be calculated based on the concentration curve following consumption of the fruit juice.

Changes in gut microbiota diversity

Time Frame: 14 days

Difference in gut microbiota Shannon index, from baseline to the end of intervention.

Changes in gut microbiota characterization

Time Frame: 14 days

Differences in gut microbiota taxonomic characterization from baseline to the end of the intervention.

Changes in the iAUC (pmol/L*min) for glucagon-like peptide-1 (GLP-1)

Time Frame: 14 days

GLP-1 will be measured in fasting and every 30 minutes up to 3 hours. The iAUC (pmol/L\*min) for GLP-1 will be calculated based on the concentration curve following consumption of the fruit juice.

Changes in the iAUC (pmol/L*min) for peptide YY (PYY)

Time Frame: 14 days

PYY will be measured in fasting and every 30 minutes up to 3 hours. The iAUC (pmol/L\*min) for PYY will be calculated based on the concentration curve following consumption of the fruit juice.

Secondary Outcomes

  • Changes in fasting glucose(14 days)
  • Changes in fasting insulin(14 days)
  • Changes in HOMA-IR(14 days)
  • Changes in total cholesterol(14 days)
  • Changes in LDL cholesterol(14 days)
  • Changes in HDL cholesterol(14 days)
  • Changes in expired breath H2(14 days)
  • Changes in faecal calprotectin(14 days)
  • Changes in triacylglycerols(14 days)
  • Changes in high sensitivity PCR(14 days)
  • Changes in expired breath CH4(14 days)
  • Changes in faecal butyrate(14 days)
  • Changes in faecal alkaline phosphatase (ALP)(14 days)
  • Changes in faecal acetate(14 days)
  • Changes in faecal LPS(14 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials